|

PRGN-2009 plus Pembrolizumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Precigen, Inc1

Indications

  • Recurrent Cervical Carcinoma1
  • HPV-Related Malignancy1
  • Metastatic Cervical Cancer1
  • HPV-Related Carcinoma1
  • Cervical Cancer1

Little Rock, Arkansas1 trial

PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

University of Arkansas for Medical Sciences

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.